OR WAIT null SECS
May 10, 2023
EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.
GSK’s Alexvy vaccine is the first to receive FDA approval for respiratory syncytial virus.
May 08, 2023
The recent revision is intended to provide guidance on QRM principles and tools that can be used for different aspects of pharmaceutical quality.
May 03, 2023
Competition in the organ-on-a-chip market increases as NETRI enters the arena.
May 02, 2023
This specific guidance refers to a DCT as a clinical trial where some or all the trial-related activities occur at locations other than traditional clinical trial sites.
Strike action is impacting numerous sectors across Europe, including the bio/pharma industry.
April 28, 2023
The event, cosponsored by FDA and USP, hosted regulators and industry leaders to discuss the challenges in strengthening the medical product supply chain.
clonoSEQ Assay is authorized by FDA for MRD assessment in lymphoid malignancies and is highly accurate, sensitive, and standardized compared to other technologies used for disease burden assessment.
April 25, 2023
Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.
The leaked study summary found that Carvykti (ciltacabtagene autoleucel) reduced disease progression by 74%.